John W. Martin
Corporate Officer/Principal chez The European Commission
Profil
John W.
Martin was the founder of Ark Therapeutics Group Plc, which was founded in 1997, where he held the title of Chief Scientific Officer from 1997 to 2010.
Currently, he is the Chairman of Cardiovascular Medicine at University College London and the Chairman of the Expert Cardiovascular Committee at The European Commission.
In the past, he held the position of Member of the Animal Procedures Committee at the United Kingdom Ministry of Home Affairs from 1998 to 2006, Head of Pharmacology & Cardiovascular Research at Wellcome Research Laboratories from 1986 to 1996, and Vice President at The European Society of Cardiology in 2002.
Postes actifs de John W. Martin
| Sociétés | Poste | Début |
|---|---|---|
| The European Commission | Corporate Officer/Principal | 25/11/2010 |
| University College London | Corporate Officer/Principal | - |
Anciens postes connus de John W. Martin
| Sociétés | Poste | Fin |
|---|---|---|
| United Kingdom Ministry of Home Affairs | Corporate Officer/Principal | 01/01/2006 |
| The European Society of Cardiology | Corporate Officer/Principal | 01/01/2002 |
| Wellcome Research Laboratories | Directeur Technique/Scientifique/R&D | 01/01/1996 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
| United Kingdom Ministry of Home Affairs | Government |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
| The European Commission | Government |
| Wellcome Research Laboratories | |
| The European Society of Cardiology |
